SK Bioscience Obtains Product Approval for Novavax COVID-19 Vaccine
[Asia Economy Reporter Lee Seon-ae] SK Bioscience announced on the 12th that it has obtained domestic product approval from the Ministry of Food and Drug Safety for Novavax's COVID-19 vaccine.
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
SK Bioscience explained, "The recombinant SARS-CoV-2 antigen protein contained in the vaccine induces the formation of antibodies against the SARS-CoV-2 virus in the body, and when exposed to SARS-CoV-2 thereafter, it triggers an immune response, thereby preventing COVID-19."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
